Calpain 3 and CaMKIIβ signaling are required to induce HSP70 necessary for adaptive muscle growth after atrophy. by Kramerova, Irina et al.
UCLA
UCLA Previously Published Works
Title
Calpain 3 and CaMKIIβ signaling are required to induce HSP70 necessary for adaptive 
muscle growth after atrophy.
Permalink
https://escholarship.org/uc/item/80r2t7pc
Journal
Human molecular genetics, 27(9)
ISSN
0964-6906
Authors
Kramerova, Irina
Torres, Jorge A
Eskin, Ascia
et al.
Publication Date
2018-05-01
DOI
10.1093/hmg/ddy071
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
O R I G I N A L A R T I C L E
Calpain 3 and CaMKIIb signaling are required to induce
HSP70 necessary for adaptive muscle growth
after atrophy
Irina Kramerova1,2,*, Jorge A. Torres1,2,†, Ascia Eskin2,3, Stanley F. Nelson2,3
and Melissa J. Spencer1,2,*
1Department of Neurology, David Geffen School of Medicine, 2Center for Duchenne Muscular Dystrophy and
3Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA
90095, USA
*To whom correspondence should be addressed at: Department of Neurology, David Geffen School of Medicine and Center for Duchenne Muscular
Dystrophy, 635 Charles E. Young Drive, South, NRB, Room 407, Los Angeles, CA 90095, USA. Tel: þ1 3102674582; Fax: þ1 3102061998;
Email: ikramero@ucla.edu (I.K.); Department of Neurology, David Geffen School of Medicine and Center for Duchenne Muscular Dystrophy, 635 Charles E.
Young Drive, South NRB, Room 401, Los Angeles, CA 90095, USA. Tel: þ1 3107945225; Fax: þ1 3102061998; Email: mspencer@mednet.ucla.edu (M.J.S.)
Abstract
Mutations in CAPN3 cause autosomal recessive limb girdle muscular dystrophy 2A. Calpain 3 (CAPN3) is a calcium dependent
protease residing in the myofibrillar, cytosolic and triad fractions of skeletal muscle. At the triad, it colocalizes with calcium
calmodulin kinase IIb (CaMKIIb). CAPN3 knock out mice (C3KO) show reduced triad integrity and blunted CaMKIIb signaling,
which correlates with impaired transcriptional activation of myofibrillar and oxidative metabolism genes in response to
running exercise. These data suggest a role for CAPN3 and CaMKIIb in gene regulation that takes place during adaptation to
endurance exercise. To assess whether CAPN3- CaMKIIb signaling influences skeletal muscle remodeling in other contexts,
we subjected C3KO and wild type mice to hindlimb unloading and reloading and assessed CaMKIIb signaling and gene
expression by RNA-sequencing. After induced atrophy followed by 4 days of reloading, both CaMKIIb activation and expres-
sion of inflammatory and cellular stress genes were increased. C3KO muscles failed to activate CaMKIIb signaling, did not
activate the same pattern of gene expression and demonstrated impaired growth at 4 days of reloading. Moreover, C3KO
muscles failed to activate inducible HSP70, which was previously shown to be indispensible for the inflammatory response
needed to promote muscle recovery. Likewise, C3KO showed diminished immune cell infiltration and decreased expression
of pro-myogenic genes. These data support a role for CaMKIIb signaling in induction of HSP70 and promotion of the inflam-
matory response during muscle growth and remodeling that occurs after atrophy, suggesting that CaMKIIb regulates re-
modeling in multiple contexts: endurance exercise and growth after atrophy.
†
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Introduction
Limb girdle muscular dystrophy 2A (LGMD2A) is an autosomal
recessive, progressive muscle-wasting disorder and is one of
the most prevalent forms of LGMD, accounting for 30% of all
LGMDs (1). LGMD2A is caused by mutations in the CAPN3 gene,
which encodes a non-lysosomal Ca2þ-dependent proteinase
named calpain 3 (CAPN3) (2). CAPN3 is a member of a larger
family of calcium dependent proteases, but CAPN3 is unique in
that it is primarily restricted to skeletal muscle (3). At this time,
CAPN3’s role in muscle and the underlying reason for why loss
of function mutations cause LGMD2A is still not well under-
stood. CAPN3 deficient muscles preserve normal sarcolemmal
integrity even following a period of exercise (4,5). The strong
sarcolemmal integrity in this disease distinguishes it from the
dystrophinopathies and suggests an altogether different patho-
mechanism of disease.
We previously generated a Capn knock out mouse (C3KO) (6),
that replicates several features of LGMD2A including small fiber
diameter and abnormal mitochondria (7). C3KO mice fail to re-
gain muscle mass after atrophy and fail to remodel after exer-
cise training (4,8). In addition, their muscles do not activate
genes involved in the slow program, including slow twitch myo-
fibrillar and oxidative metabolism genes (8,9). These studies
suggest that CAPN3 is involved in re-growth after atrophy or a
switch to the slow program after exercise training, thus estab-
lishing a role for CAPN3 in post-natal adaptive muscle growth
and remodeling.
CAPN3 has been biochemically localized to multiple subcel-
lular compartments of skeletal muscle, suggesting that it may
play different roles at each subcellular location. In the sarco-
mere, CAPN3 interacts with the myofibrillar protein titin at two
different sites: the N2-line and M-line (10). Ojima et al. (11)
showed that CAPN3 undergoes dynamic changes in its distribu-
tion upon sarcomere extension and that this movement re-
quires protease activity. These studies support the hypothesis
that sarcomere-associated CAPN3 may act as a sensor of me-
chanical stretch and are consistent with the hypothesis that
CAPN3 plays a role in muscle adaptation.
In addition to its location in the myofibrillar fraction, CAPN3
is also present in the cytosolic and membrane fractions of skele-
tal muscle (12,13). At the membrane, CAPN3 co-localizes with
the triad-associated protein complex, which is the site of Ca2þ
release to initiate muscle contraction (aka excitation–contrac-
tion coupling). CAPN3 association with triads appears to occur
through its interaction with the ryanodine receptor (RyR1), the
calcium release channel located in the sarcoplasmic reticulum
membrane (12). In the absence of CAPN3, levels of RyR1 and
other triad proteins (dihydropyridine receptor a subunit, aldol-
ase, CaMKIIb and others) are reduced, suggesting that CAPN3
plays a structural role in maintaining the integrity of this triad
complex. Importantly, decreased concentrations of CAPN3 pro-
tein in LGMD2A patient biopsies are also accompanied by re-
duced levels of RyR1 (9). Consistent with the observed reduction
in RyR1 protein levels, we found that Ca2þ fluxes elicited by sin-
gle action potentials or by tetanic stimulation were significantly
reduced in C3KO muscles (12,14). These results identified a
novel role for CAPN3 in maintenance of the triad-associated
protein complex and muscle Ca2þ handling.
Ca2þ-mediated signaling plays an important role in muscle
adaptation (15). The reduction in Ca2þ release that we observed
in C3KO muscles led us to survey Ca2þ-mediated signaling path-
ways, leading to the observation that CaMKIIb-mediated signal-
ing is blunted in C3KO mice subjected to treadmill running (8,9).
Moreover, we demonstrated that failure to activate CaMKIIb sig-
naling after exercise is a specific feature of C3KO muscles. In
contrast, when dystrophic mdx mice (a model for Duchenne
Muscular Dystrophy) were subjected to a similar running proto-
col (8), their muscles properly activated CaMKIIb signaling, al-
though they exhibit some maladaptation to exercise (16,17).
CaMKII is a calcium calmodulin-dependent, serine/threo-
nine kinase that has been previously shown to influence gene
transcription in a number of different tissues (18,19). CaMKII
mediates its effects through a variety of downstream signaling
pathways that ultimately regulate gene transcription in the nu-
cleus, depending on the external cues. In skeletal muscle,
CaMKII has been associated with phosphorylation of histone
deacetylases (HDACs), leading to their export from the nucleus
(20). Removal of HDAC repression on chromatin permits MEF2-
mediated transcription of slow phenotype genes. Consistent
with impaired CAMKIIb signaling in C3KO muscles, we observed
a reduction in the slow fiber phenotype (8,9). Moreover, C3KO
mice fail to up-regulate specific gene sets that are normally in-
duced in remodeling following endurance exercise. Specifically,
exercised C3KO mice failed to activate myofibrillar and lipid me-
tabolism genes. In addition, we showed that running exercise
activates CaMKII-p38-PGC1a (peroxisome proliferator-activated
receptor gamma coactivator 1-alpha) signaling in wild type
(WT) but not in C3KO mice; this signaling defect likely leads to
the observed impairment in metabolic gene expression. Thus,
CAPN3 and CaMKII regulate downstream signaling that induces
adaptive gene expression following endurance exercise. The in-
ability to properly activate CaMKIIb and downstream gene ex-
pression programs that facilitate muscle adaptation to exercise
may underlie LGMD2A.
Since our data showed a role for CaMKIIb in skeletal muscle
adaptation after running exercise, we sought to determine
whether this pathway might facilitate muscle adaptation in
other contexts, particularly in the context of muscle re-growth
that occurs after a bout of atrophy. Previous studies in the C3KO
mouse demonstrated insufficient and delayed growth after a
bout of muscle atrophy, despite proper activation of the insulin-
like growth factor-RAC-alpha serine/threonine-protein kinase
(IGF-Akt) signaling pathway, a principal regulator of adult mus-
cle growth (4). In this study, we tested this hypothesis using a
model of muscle adaptation, called hindlimb suspension/
reloading (HS/RL) in which adult muscle growth is stimulated
by reloading after a period of disuse. This loading-dependent
muscle growth has been shown to entail three major processes;
(i) stimulation of protein synthesis; (ii) suppression of protein
degradation and (iii) activation of muscle precursor cells (MPCs)
that facilitate regeneration and growth. In addition, it had been
shown that hypertrophic signals trigger induction of a cellular
stress response, in particular, expression of HSPs that appear to
be vital for muscle growth (21,22).
In these studies we showed that the absence of CAPN3 and
reduction of CaMKIIb activation impact adaptive gene expres-
sion during muscle growth after atrophy. Thus, these studies
suggest that CaMKIIb acts as an upstream signal to orchestrate
muscle adaptation in response to different external cues.
Results
Attenuated muscle growth after disuse in C3KOmice
The CAPN3-CaMKIIb axis was previously shown to play a role in
muscle adaptation to running exercise (8,9). To examine the
role of this relationship in a second context of muscle
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remodeling, we subjected WT and C3KO mice to HS/RL.
Previous studies by our group and others have shown that HS
leads to a decrease in soleus weight by 40% after 10 days of
suspension (23). Once mice return to normal cage activity, mus-
cle growth increases significantly between 2 and 4 days of RL
and muscle mass is restored within 10–14 days (24). Previously
we showed that the average cross-sectional area increased by
43.1% after 4 days of reloading in C57 BL/6 mice, whereas C3KO
muscles only demonstrated an increase of 6.1% (4). In this
study, these findings were reproduced. WT soleus muscle
weight was increased by 33% after 4 days of RL while C3KO so-
leus weight did not change significantly (Fig. 1A); thus, our stud-
ies confirmed that CAPN3 deficient muscles consistently
demonstrate adaptation failure in at least two different con-
texts of remodeling: running and reloading after atrophy.
We next asked whether the observed growth failure in C3KO
mice was associated with impaired activation of CaMKIIb. Both
CaMKIIb and activated (phosphorylated) CAMKII were increased
in WT reloaded solei, suggesting that CaMKII-mediated signal-
ing may be a universal signal that is important for remodeling
in a number of contexts (Fig. 1B). C3KO solei failed to increase
CaMKIIb levels in response to muscle reloading, implicating
failed CaMKIIb signaling in attenuated muscle growth after at-
rophy in C3KO.
Comparison of genes differentially regulated in
response to running exercise or muscle reloading
In our prior studies we showed that blunted CaMKIIb signaling
in C3KO mice correlated with failure to activate an adaptive
gene signature in response to running exercise (8). To deter-
mine whether failure to properly activate CaMKIIb also corre-
lated with inadequate activation of genes involved in adaptive
muscle growth, we assessed gene expression patterns by RNA-
seq in WT and C3KO solei subjected to HS/RL. RNA-seq is a
sensitive and unbiased method of assessing and comparing
transcriptomes (25). We first identified a set of genes that were
differentially expressed between WT HS and WT RL muscles
(i.e. a ‘normal gene signature’) and then compared this set of
genes to those activated in C3KO HS versus C3KO RL muscles,
to identify genes that were aberrantly expressed in the absence
of CAPN3. An outline of the experiment is shown in Figure 1C.
As shown in Table 1, some commonly observed gene clusters
were upregulated under conditions of running or reloading, in-
cluding genes involved in actin cytoskeletal rearrangements,
cell adhesion and migration, as well as genes encoding extra-
cellular matrix (ECM) and myofibrillar proteins. The most signif-
icant difference revealed by these comparisons was the
expression pattern of metabolic genes, which were significantly
upregulated in WT muscles in response to running exercise [(8)
and Supplementary Material, Fig. S1]. In contrast, genes in-
volved in oxidative and lipid metabolism were significantly
downregulated in WT muscles after reloading (Fig. 2).
Interestingly, C3KO muscles failed to regulate the same set of
genes induced in WT muscles in both running and HS/RL, sug-
gesting that failure of C3KO muscles to sense and respond ap-
propriately to loading cues occurs in at least two settings of
muscle adaptation. These studies demonstrate that an aberrant
transcriptional response during remodeling is a common fea-
ture of CAPN3 deficiency.
Figure 1. Muscle growth after a period of disuse was attenuated in C3KO mice. (A) Weight of the soleus muscles in WT and C3KO mice at the end of the suspension pe-
riod (susp) and after 4 days of reloading (reload). (B) CaMKII was activated in response to muscle reloading in WT but not in C3KO muscles. Western blot analysis of
CaMKIIb and activated (P- Thr286) CaMKII in suspended versus reloaded muscles of WT and C3KO muscles. Quantitative analysis of the western blot is shown to the
right. Asterisks indicate statistical significance with P < 0.05 considered statistically significant. Vertical bars represent standard deviation, n ¼ 3 for each group. (C) An
outline of the RNA-seq experiment and data analysis.
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Reduced immune response to muscle reloading in
C3KOmice
Muscle reloading is accompanied by a burst of intramuscular in-
filtration that predominantly consists of myeloid cells (macro-
phages, neutrophils and eosinophils). These cells play an
important role in promoting muscle growth and recovery after a
period of disuse (26,27). We observed that genes involved in the
innate immune response represented the most abundant set of
upregulated genes in WT RL muscle; however, this coordinated
response was absent in C3KO muscles (Table 1 and Fig. 3).
Specifically, we found that genes expressed by monocyte/macro-
phages and granulocytes were decreased in C3KO RL muscles
compared with WT RL muscles (Table 2). RT-PCR confirmed the
RNA-seq results and demonstrated that expression of the two
common myeloid cell markers, CD11b and CD11c, was not in-
duced by RL in C3KO muscles. Furthermore, the overall expres-
sion of these markers was significantly lower in C3KO RL muscles
compared to WT RL muscles (Fig. 4A). In agreement with these
gene expression results, C3KO RL muscles showed a reduced
number of CD68-positive macrophages on tissue sections
(Fig. 4B). These studies demonstrate that C3KO muscles fail to
mount a proper immune response during muscle reloading.
Decreased expression of myogenic factors in
C3KOmuscles
Macrophages secrete cytokines and growth factors that directly
influence the proliferation and differentiation of MPCs. In ex-
perimental models of muscle injury, interference with normal
immune cell influx leads to a delay in muscle regeneration [re-
viewed in (28)]. Our RNA-seq analysis revealed decreased ex-
pression of several chemokines in C3KO mice, particularly the
CC family chemokine monocyte chemotactic protein 1 (MCP-1)
and its structural homolog MCP-5. RT-PCR confirmed that MCP-
1 and MCP-5 were significantly decreased in C3KO RL muscle
compared to WT RL muscle (Fig. 4C). In agreement with the pro-
posed roles for the CC chemokines in controlling cell prolifera-
tion (29), RNA-seq data demonstrated that a set of genes
involved in DNA replication and cell proliferation was signifi-
cantly up-regulated in WT mice but not in C3KO mice upon
muscle reloading (Fig. 5A).
Analysis of the total muscle transcriptome reflects changes
in all cell types present, including MPCs, fibroblasts and im-
mune cells. Thus, the differential expression of genes involved
in DNA replication and proliferation presented in Figure 5A may
reflect changes in proliferation of several cell types. Since MCP-
1 was shown to directly regulate proliferation of MPCs (29), we
next examined whether decreased levels of MCP-1 correlated
with decreased expression of the markers of myogenesis in
C3KO muscles. Indeed, we found that expression levels of the
transcription factor myogenin, a key marker of myogenic differ-
entiation (30), as well as a direct target of myogenin, Chrng (a
marker of terminal myogenic differentiation), were both signifi-
cantly reduced in C3KO reloaded muscles compared to WT
reloaded muscles, by RNA-seq and RT-PCR analysis (Fig. 5B).
Collectively, these data suggest that in the absence of CAPN3
and an attenuated immune response, proliferation and differ-
entiation of MPCs is reduced.
Hsp70 is not upregulated in C3KOmuscles under
mechanical stress conditions
Damage-associated molecular patterns deliver signals that
drive systemic responses to injury or stress, such as inflamma-
tion. One such molecule is high-mobility group box 1 (HMGB1)
or alarmin. Intracellular HMGB1 can act as a DNA binding pro-
tein that modulates transcription, or HMGB1 can also be se-
creted by muscle and act as a pro-inflammatory cytokine (31).
We assessed HMGB1 expression in our RNA-seq data and found
that its expression was similar in WT and C3KO muscle
(Supplementary Material, Fig. S2).
The other molecule implicated in activation of the innate
immune response is inducible heat shock protein 70 (HSP70).
HSP70 not only acts as an intracellular molecular chaperone
that protects against cellular damage but it can also be secreted
and act as a DAMP in response to various stressful conditions,
including experimentally induced injury and exercise (32).
HSP70 can activate both macrophages and neutrophils (33,34).
Moreover, in vivo studies demonstrated that genetic ablation of
hsp70 attenuates the inflammatory response to muscle injury or
reloading and severely impairs muscle regeneration (35).
Figure 2. Downregulation of oxidative metabolism genes in WT but not C3KO
muscles after 4 days of reloading. Shown is a heat map diagram of the expres-
sion levels (identified by RNA-seq) of oxidative metabolism genes in WT and
C3KO muscles at the end of the suspension period (susp) or after 4 days of
reloading (reload) (n ¼ 6 for each group of mice).
Table 1. Differentially expressed genes in WT exercised versus
reloaded muscles
Gene category 5 days running 4 days reloading
Myofibrillar * 22.9% * 2.4%
ECM, adhesion, migration * 22.9% * 17.8%
Actin cytoskeleton * 6% * 12%
Stress response, chaperons * 3.6% * 2.4%
Signaling, receptors ND + 15.6%
Signaling, transcription + 36.2% ND
Mitochindrial, oxidativeand
lipid metabolism
* 30.1% + 67.9%
Immune response ND * 27.9%
Cell proliferation and growth ND * 14.9%
Angiogenesis ND * 3.4%
Growth and development + 48.9% ND
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We examined our RNA-seq data to determine if HSP70 was
differentially expressed between WT and C3KO muscles. HSP70 is
encoded by two genes, hspa1a and hspa1b, whose products differ
by only two amino acids and are believed to be functionally inter-
changeable proteins (collectively referred to as HSP70). These
genes were found to be differentially regulated in C3KO com-
pared to WT RL muscles (Supplementary Material, Fig. S3A). RT-
PCR validation and western blot analysis confirmed that C3KO
muscles had lower levels of HSP70 in the HS condition and that
C3KO muscles failed to upregulate HSP70 expression to the same
extent as WT muscles during RL (Fig. 6A and B, upper panel). Of
note, we observed differential expression of several other hsp
genes between RL C3KO and WT muscles (Supplementary
Material, Table S1). Transcription of many heat shock genes is
controlled by heat shock factor 1 (HSF-1) (36). Under our experi-
mental conditions, HSF-1 was upregulated in WT but not in C3KO
RL muscle (Fig. 6B and C). In parallel, expression of HSP90, a com-
ponent of the HSF-1 protein complex and a transcriptional target
of HSF-1, was also reduced in C3KO muscles compared with WT
muscles (Fig. 6B and C).
HSP70 expression and secretion has also been shown to be
induced in response to endurance exercise (32). Previously, we
found that C3KO muscles were not able to fully activate the
proper program of gene expression in response to this type of
exercise (8), thus we sought to investigate whether HSP70 in-
duction occurred normally in C3KO muscles in this context.
As shown in Figure 7A and B, HSP70 was increased in WT exer-
cised muscles but was not increased in C3KO muscles. Taken
together, these data suggest that the CAPN3/CAMKII axis is im-
portant for activation of stress signals necessary for muscle re-
modeling and adaptation.
CaMKII activation controls HSP70 induction in response
to stress conditions
It is well known that multiple signaling pathways can control
induction of HSPs. In cardiomyocytes, CaMKIId regulates the
stress response through expression of inducible HSP70 (37). Our
data also demonstrate a correlation between activated CaMKIIb
and the expression of HSP70 in RL muscles (Figs 1B and 7A).
Based on these observations, we hypothesized that CaMKIIb
may also be involved in regulating cell stress response, includ-
ing expression of HSP70, in skeletal muscle cells.
To directly test the hypothesis that CaMKIIb signaling acti-
vates HSP70 expression in response to cellular stress in a simple
model system, we used C2C12 muscle cells. We first analyzed
the expression of different forms of CaMKII in these cells during
myogenic differentiation. As shown in Supplementary Material,
Figure S4A and B, CaMKIId is the only form of CaMKII that is ex-
pressed in myoblasts, but during the course of differentiation,
Figure 3. Upregulation of inflammatory response genes in WT but not C3KO
reloaded muscles. Shown is a heat map diagram of expression levels of immune
response genes in WT and C3KO muscles at the end of the suspension period
(susp) or after 4 days of reloading (reload) (n ¼ 6 for each group of mice).
Table 2. CD markers expressed by cells involved in innate immunity (monocytes/marcrophages and granulocytes); RNA-seq data
Gene WT susp, average WT reload, average KO susp, average KO reload, average WT reload/KO reload P-value, reload*
Ptprc(Cd45) 0.52 1.66 0.37 0.80 2.08 0.006
Itgam (CD11b) 0.77 2.96 0.48 1.31 2.02 0.012
Itgax (CD11c) 0.07 0.42 0.14 0.21 2 0.029
Cd14 1.69 3.77 0.80 1.72 2.19 0.036
Cd33 0.35 1.05 0.21 0.54 1.94 0.023
Cd37 1.53 3.64 1.13 1.49 2.44 0.033
Cd38 1.69 4.27 1.49 1.64 2.6 0.011
Cd40 0.66 1.84 0.38 0.54 3.4 0.117
Cd44 1.38 8.65 1.15 4.79 1.81 0.061
Cd48 1.25 2.75 0.54 1.38 1.99 0.013
Cd52 4.28 15.00 1.52 3.61 4.16 0.020
Cd53 0.78 2.67 0.44 1.32 2.02 0.002
Cd63 145.17 243.37 120.02 153.92 1.58 0.045
Cd74 54.19 126.47 26.12 65.26 1.94 0.022
Cd81 54.79 110.08 47.51 71.65 1.53 0.016
Cd84 0.47 2.14 0.31 0.94 2.28 0.012
Cd86 0.56 1.62 0.20 0.53 3.06 0.002
Cd93 4.24 15.68 4.12 7.22 2.17 0.008
Cd97 9.10 23.04 11.12 15.34 1.5 0.001
Cd209d 2.22 3.35 1.39 1.54 2.18 0.031
*Student’s test was used to calculated P values of WT reloaded versus KO reloaded (n ¼ 6 for each group of mice).
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CAMKIId decreases significantly and CaMKIIb and CaMKIIc be-
come the major forms present in myotubes. Levels of HSP70 re-
main the same during myogenic differentiation (Supplementary
Material, Fig. S4C). Based on these observations we chose to
conduct further experiments with fully differentiated myo-
tubes, because they are more representative of muscle fibers.
To determine whether CaMKII activation is responsive to
cell stress in the C2C12 system, 6-day myotubes were incubated
with different concentrations of H2O2. This treatment induced a
cell stress response and CaMKIId activation in cardyomyocytes
(37). As shown in Supplementary Material, Figure S5, incubation
with H2O2 caused a dose-dependent activation of CaMKb and in-
duced expression of HSP70 in C2C12 myotubes. Moreover, we
showed the HSP70 induction is specific to CaMKII activation,
since inhibition of CaMKII activity with KN93 completely abol-
ished the HSP70 induction (Fig. 7C and D). These results show
that CaMKII is involved in regulation of HSP70 expression in re-
sponse to stress conditions in skeletal muscle cells.
We next sought to determine whether restoring CaMKII acti-
vation in vivo would also reestablish HSP70 induction in re-
sponse to exercise. Our studies showed that HSP70 is similarly
induced by exercise or muscle reloading (Figs 6 and 7); thus, we
chose to use treadmill running to test this question (as a less
stressful procedure than HS/RL). Previous data suggest that
CAPN3 helps to maintain the structural integrity of the triad
protein complex necessary for normal Ca2þ release (12,14). To
address whether restoration of triad integrity and Ca2þ release
would restore CaMKIIb activation and HSP70 levels, we used a
knock-in (KI) mouse model generated by Ojima et al. (13), in
which the WT Capn3 gene was replaced with its proteolytically
inactive C129S mutant (C129S KI). These mice possess some
pathological features of calpainopathy, however, structural in-
tegrity of the triad and Ca2þ release upon activation were com-
pletely restored compared to C3KO mice (12–14). To test
whether restoration of the triad and Ca2þ would normalize
CaMKIIb and HSP70 levels, we subjected C129S KI mice to run-
ning exercise and assessed activation of CaMKIIb by western
blotting. We found that CaMKIIb activation was indeed
Figure 4. Attenuated leukocyte influx into C3KO muscles after 4 days of reload-
ing. (A) RT-PCR validation of expression levels of the two common leukocyte
surface markers CD11b and CD11c encoded by itgam and itgax genes, respec-
tively. (B) Representative micrographs of cross sections from WT suspended
(susp) and reloaded (reload) muscles stained for macrophage marker CD68 (left
panel); quantitative analysis of CD68þ cells on WT and C3KO muscle sections
(right panel). (C) RT-PCR validation of expression levels of MCP-1 and its homo-
log MCP-5 encoded by Ccl2 and Ccl12 genes, respectively. In each graph of RT-
PCR validation, the expression level of the reloaded (reload) group is graphed
relative to the suspended group (susp); the average expression of each gene in
the suspended group was set at 100% for each genotype. Asterisks indicate sta-
tistical significance with P < 0.05 considered statistically significant. Vertical
bars represent standard deviation, n ¼ 3 for each group.
Figure 5. Decreased expression of cell proliferation and myogenic differentia-
tion genes in C3KO reloaded muscles. (A) A heatmap diagram of the expression
levels (identified by RNA-seq) of DNA replication and cell proliferation genes in
WT and C3KO muscles at the end of the suspension period (susp) or after 4 days
of reloading (reload) (n ¼ 6 for each group of mice) (B) RT-PCR validation of ex-
pression levels of a key myogenic transcription factor myogenin and its target
gene Chrng coding for the gamma subunit of the acetyl choline receptor. In each
graph of RT-PCR validation, the expression level of the reloaded (reload) group is
graphed relative to the suspended group (susp); the average expression of each
gene in the suspended group was set at 100% for each genotype. Asterisks indi-
cate statistical significance with P < 0.05 considered statistically significant.
Vertical bars represent standard deviation, n ¼ 3 for each group.
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normalized when structurally intact CAPN3 was restored.
Accordingly, the induction of HSP70 in response to running ex-
ercise was also restored (Fig. 7E and F). Taken together these
data suggest that the Capn3 and CaMKII-mediated signaling
regulates expression of inducible HSP70 in response to physio-
logical stress in skeletal muscle cells.
Discussion
Skeletal muscle has the capacity to remodel in response to dif-
ferent types of muscle activity, oxygen changes, nutrient avail-
ability and hormonal status (38). The ability of muscle to sense
and distinguish these cues is crucial for its adaptive response,
i.e. activation of a specific set of signaling pathways that regu-
late gene expression and ultimately influence its phenotype.
We previously showed that CAPN3/CaMKIIb signaling is one
such pathway that is activated after running exercise and this
signaling is blunted in C3KO muscles, thus compromising their
ability to adapt and switch to a more oxidative phenotype (8,9).
These results led to the hypothesis that the triad protein com-
plex, that includes CAPN3, and CaMKIIb may act as a sensor of
environmental cues that trigger muscle adaptation.
To determine the extent to which CaMKII-mediated signal-
ing is involved as a global trigger of adaptation and remodeling,
we utilized HS/RL to elicit a different type of muscle adaptation.
In this study, we demonstrate that CaMKIIb is similarly
activated during HS/RL, and showed that this pathway is atten-
uated in CAPN3 deficient muscles. Thus, CAPN3–CaMKIIb-medi-
ated signaling appears to orchestrate muscle remodeling in at
least two conditions that trigger muscle remodeling. However,
we observed that gene expression patterns differ, suggesting
that downstream targets of CAPN3/CaMKII-signaling fluctuate
depending on the type of loading that the muscle experiences.
These results suggest that CaMKII is a nodal point that is fine
tuned by downstream signals, to modulate the adaptive re-
sponse to match the type of loading cues.
In these studies, we showed that RL induces activation of
cell stress response genes and that this process is attenuated in
CAPN3 deficient muscles. For example, expression of inducible
HSP70 is not activated in C3KO muscles compared to WT mus-
cles. Recent studies using genetic ablation and overexpression
of HSP70 have provided significant experimental evidence that
HSP70 is indispensable in muscle adaptation and recovery after
injury. Hsp70 transgenic mice are less susceptible to muscle in-
jury following lengthening muscle contractions and these mice
also showed improved muscle recovery (39). In a cryolesioning
injury model, injection of an HSP70-expressing plasmid 3 days
post-injury was shown to enhance muscle regeneration (40),
thus demonstrating that increased HSP70 not only protects
against muscle damage but also intensifies the muscle recovery
process. HSP70 KO mice subjected to cardiotoxin-induced mus-
cle injury showed a delayed inflammatory response that was
associated with increased fibrosis and decreased muscle regen-
eration and fiber growth. Injection of recombinant HSP70 to
HSP70 KO muscle at the time of injury was shown to restore
normal immune cell infiltration to the site of injury (32,35).
The exact mechanisms of how HSP70 regulates the immune re-
sponse still remain to be elucidated. It is possible that secreted
HSP70 may act as a DAMP through direct interaction with im-
mune cells to facilitate the immune response.
Transcription of heat shock genes is controlled by HSFs (41).
Among those HSFs, HSF-1 plays a crucial role in inducing ex-
pression of hsp genes in response to various stress conditions
and is expressed at the highest level in skeletal muscles
Figure 6. Inducible HSP70 was not appropriately unregulated in C3KO muscles in response to reloading. (A) RT-PCR validation of expression levels of hspa1a gene
encoding inducible HSP70, in suspended (susp) and reloaded (reload) muscles. The expression level of the reloaded (reload) group is graphed relative to the suspended
group (susp); the average expression of hspa1a gene in the suspended group was set at 100% for each genotype. (B) Western Blot analysis of the expression levels of
HSP70, HSF-1 and HSP90 in suspended (susp) and reloaded (reload) muscles of WT and C3KO muscles. (C) Quantitative analysis of the western blots shown in (B).
Asterisks indicate statistical significance with P < 0.05 considered statistically significant. Vertical bars represent SD, n ¼ 3 for each group.
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(according to our RNA-seq data). HSF-1 deficiency was shown to
delay muscle growth in response to various stimuli including RL
after disuse atrophy, compensatory overloading and heat stress
(21,22,42). Our data showed that HSF-1 is greatly reduced in
C3KO RL muscles (Fig. 6). Activation of the stress response by
HSF-1 occurs downstream of multiple signaling pathways in-
cluding Ca2þ-CaMKII (37) and our data are consistent with the
notion that CaMKII signaling is necessary for induction of
HSP70.
In these studies, we observed that the reduction in HSP70
correlates with decreased infiltration of immune cells in C3KO
muscles during muscle reloading. Interestingly, while inflam-
mation is a very common feature of many muscular dystro-
phies, LGMD2A biopsies are distinguished in that most
demonstrate an eosinophilia at the earliest stages of the disease
(43–45). In contrast, in Duchenne muscular dystrophy, the infil-
trate is primarily comprised of monocytes/macrophages and
neutrophils (46,47). It is possible that the reduction in these my-
eloid populations in LGMD2A muscles is due to a compromised
ability to initiate a stress response following increased muscle
loading or damage.
It is widely accepted that immune cells must infiltrate in-
jured muscle with a particular order and timing in order to
achieve successful muscle recovery, as immune cells remove
necrotic fiber debris and secrete pro-myogenic factors that
control both MPC proliferation as well as terminal myogenic dif-
ferentiation (28). Our RNA-seq analysis revealed decreased ex-
pression of DNA replication and cell proliferation genes,
decreased pro-myogenic cytokines, and a concomitant down-
regulation of myogenin in C3KO RL muscles compared to WT RL
muscles. This observation supports the notion that reduction in
myoblast activation may be one of the reasons that C3KO mus-
cles fail to grow following HS/RL. There are conflicting reports in
the literature on whether or not activation of MPCs is required
for muscle growth after a period of disuse (48). Our data of in-
creased expression of cell proliferation genes and myogenin
suggest that activated MPSs contribute to muscle growth or re-
generation upon increased loading after atrophy. Taken to-
gether, our data support the hypothesis that lack of proper
activation of HSP70 in C3KO mice leads to a diminished immune
response and compromised myogenesis in response to muscle
RL. The question remains whether or not these changes reflect
a temporary delay in the C3KO growth response that can be
compensated for at later stages of recovery. The fact that C3KO
mice are born with the same weight as WT mice, but show de-
creased post-natal growth and never reach WT muscle mass (6),
suggests a deficit in post-natal growth as a primary mechanism
underlying calpainopathy.
Taken together, our data support the hypothesis that the
triad-associated protein complex (which includes CAPN3 and
Figure 7. Levels of HSP70 correlated with activation of CaMKII in C2C12 cells and in adult muscle. (A) P-CaMKII and HSP70 were upregulated in response endurance ex-
ercise in WT but not in C3KO muscles. Western blot analysis of activated P-CaMKII and HSP70 expression in WT and C3KO sedentary control muscles (sed) and muscles
subjected to running exercise (run). (B) Quantitative analysis of HSP70 western blot shown in (A). (C) HSP70 was upregulated in C2C12 myotubes in response to cell
stress caused by incubation with 0.5 mM H2O2; inhibition of CaMKII by 20 lM KN83 completely blocked HSP70 induction. (D) Quantitative analysis of the western blot
shown in (C). (E) Western blot analysis of activated P-CaMKII and HSP70 expression in CAPN3-C129S KI mice subjected to running exercise. (F) Quantitative analysis of
western blots shown in (E). Asterisks indicate statistical significance with P < 0.05 considered statistically significant. Vertical bars represent SD, n ¼ 3 for each group.
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CaMKIIb), plays a role in sensing mechanical stress induced by
at least two types of muscle loading: running exercise and
reloading after atrophy. Our data also reveal that CaMKII signal-
ing induces expression of HSP70 which signals myeloid cell in-
filtration necessary for normal muscle regeneration. In the
absence of CAPN3, immune cell influx is attenuated and expres-
sion of pro-myogenic factors is reduced. As a result, cell
proliferation and myogenic differentiation is compromised,
contributing to a growth deficit under reloading conditions ob-
served in C3KO mice.
Other factors and pathways may also contribute to the in-
ability of C3KO muscle to regrow in response to experimental in-
tervention. Recently, Yalvac et al. (49) demonstrated a failure of
C3KO muscle to regenerate after repeated cycles of cardiotoxin
injections. Muscles were examined after 4 and 12 weeks after
the last injection, which is beyond the initial phase of inflamma-
tory and regenerative responses to severe muscle injury. The
data suggest that C3KO muscles fail to adjust their metabolism
during regeneration and that this maladaptation may be attrib-
utable to altered AMPK signaling (49). In line with these observa-
tions, our RNA-seq data also demonstrated that the genes
involved in oxidative metabolism were downregulated during a
period of intense muscle growth (reloaded muscles) in WT mice
but failed to undergo similar changes in C3KO muscles (Fig. 2).
Collectively, these data suggest that the inability to activate
compensatory adult muscle growth may be responsible for the
decreased muscle mass observed in C3KO mice and typical for
LGMD2A patients. These studies also accentuate the question of
whether or not moderate physical exercise could be beneficial
for LGMD2A patients and should be taken into account when
considering proper physical therapies for these patients.
Materials and Methods
Animal use and HS/RL experiment
All experimental protocols and the use of animals were in ac-
cordance with the National Institutes of Health Guide for Care
and Use of Laboratory Animals and approved by the UCLA
Institutional Animal Care and Use Committee. C57 BL/6 (WT)
mice were obtained from the Jackson Laboratories. C3KO mice
were previously described in (6) and they are congenic to C57/
BL6. C129S KI (C129S KI) mice were generated and described by
Dr. Sorimachi’s lab (11).
WT and C3KO male mice (4–5 months of age) were subjected
to 10 days of hindlimb unloading by elevating the pelvis, so that
the feet of the hindlimb did not contact the cage floor [described
in detail in (50)]. One group of mice (suspended, n ¼ 6 for each
genotype) was sacrificed at the end of the suspension period,
while the other group (reloaded, n ¼ 6 for each genotype) was al-
lowed to return to the normal cage activity for 4 days, after
which time the mice were sacrificed and both solei were care-
fully dissected from each mouse and weighted.
Running exercise was performed according to the treadmill
running protocol described previously in (8). WT, C3KO and
C129S KI male mice (4–5 months of age) were used (n ¼ 5 per
group) for these experiments.
RNA-seq and data analysis
RNA-sequencing libraries were constructed with the TruSeq RNA
Sample Prep Kits v2 from Illumina. RNA from two animals from
the same group were combined together to generate 12 RNA sam-
ples that were indexed with different adapters and pooled for
paired-end 100 bp sequencing on two lanes of Illumina
HiSeq2000. RNA-seq reads were aligned with TopHat v2.0.8b (51)
to the mouse genome, version mm9. The average TopHat align-
ment rate was 90.67%, resulting in an average of 28.9 million
reads per sample. Transcripts were assessed by Cufflinks v2.1.1
(52), using a GTF file based on Ensemble Mus_musculus_NCBI37.
Genes were grouped in custom lists. Heatmaps were created in R,
version 2.14.1, log10 of FPKM values are shown.
Statistical analysis
Differentially expressed genes were found by Cuffdiff, as part of
the Cufflinks package (52). Cuffdiff tests the statistical signifi-
cance of the expression of different groups. This is done by test-
ing the observed log-fold change of the gene’s expression
against the null hypothesis of no change. Genes were consid-
ered significant if they satisfied a threshold of FDR multiple
testing correction value <0.05. WT reloaded samples were com-
pared to WT suspended samples with Cuffdiff. A set of genes
that were significantly different between WT reloaded and WT
suspended muscles were considered as the normal pattern of
changes in gene regulation induced by loading (‘normal gene
signature’). These genes were then assessed in the comparison
of C3KO reloaded samples to C3KO suspended samples.
For the two group comparisons two-tailed Student’s t-test
was used. One-way ANOVA was used to calculate statistical sig-
nificance when comparing multiple pairs. The statistical analy-
sis was performed using IBM SPSS Statistics software. P-values
< 0.05 were considered statistically significant.
Real-time PCR validation of RNA-seq data
cDNA was generated using iScript Reverse Transcriptase
Supermix (Bio-Rad) and was used for real-time PCR with ITaq
Universal SYBR Green Supermix (BioRad) according to manufac-
turer’s instructions. All real-time PCR reactions were run in CFX
Connect Real-Time PCR System (Bio-Rad). Primers for real-time
PCR were selected to span intron–exon junctions (when possi-
ble) and were first tested in regular PCR amplification to ensure
the production of a single band in each case. The following pri-
mer pairs were used:
Itgax (CD11c)—5’ cgagttgcagaaggccaagt (frw), 5’ aaaaagt-
catctgtgagcctcc (rev);
Itgam (CD11b)—5’ gtgctcttggctctcatcact (frw), 5’ gggaggt-
caatgcatggagaa (rev);
Ccl2 (MCP-1)—5’ ctgtcatgcttctgggcctg (frw), 5’ cttggtga-
caaaaactacagcttc (rev);
Ccl12 (MCP-5)—5’ cagtcctcaggtattggctgg (frw), 5’ atggtcct-
gaagatcacagctt (rev);
Myogenin—5’ tccagtacattgagcgcctac (frw), 5’—gagcaaat-
gatctcctgggttg (rev);
Chrnc—5’ gctgtctgcctgggggc (frw), 5’ agggcctcctctcgttcatt
(rev);
Hspa1a (HSP70) 5’—caccatcgaggaggtggattag (frw), 5’ agcc-
cacgtgcaatacacaaag (rev).
Immunohistochemistry
Frozen solei cross-sections were fixed with cold acetone for
10 min and stained with anti-CD68 antibody (AbD Serotec)
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followed by secondary anti-rat biotinylated antibody (Vector
Laboraories). Staining was visualized using AEC Peroxidase
Substrate Kit (Vector Laboratories). Slides were analyzed using
AxioVision Software from Zeiss.
Muscle extract preparation and western blot analysis
For western blot analysis, solei were homogenized in reducing
sample buffer (80 mM Tris-HCl, pH6.8, 2% sodium dodecyl sul-
fate, 10% glycerol and 0.1 M dithiothreitol) supplemented with
Halt protease and phosphatase inhibitor cocktail (ThermoFisher
Scientific). The following antibodies were used for western blot
analysis: anti-HSF-1 (Santa Cruz Biotechnology), anti-hsp70
(StressMarq), anti-hsp90 (BD Transduction Laboratories), anti-P-
CaMKII (ThermoFisher Scientific), anti-CaMKIIb (Invitrogen). The
quantitative analysis was performed using ImageJ software.
Cell culture experiments
C2C12 mouse myogenic cells were grown in Dulbecco Modified
Eagle Medium (DMEM) supplemented with 10% fetal bovine se-
rum and antibiotics (all cell culture reagents were from
ThermoFisher Scientific). To induce myogenic differentiation,
cells were washed with serum-free DMEM and transferred to
differentiation medium (DMEM supplemented with 2% horse
serum). After 6 days of differentiation, myotubes were incu-
bated overnight in the presence of 0.5 mM H2O2, with or without
CaMKII inhibitor KN93 (20 lM, Sigma). All experiments were
done in triplicates.
For western blot analysis cells were collected in PBS using cell
scraper. Cell pellets were resuspended in reducing sample buffer
(80mM Tris-HCl, pH6.8, 2% sodium dodecyl sulfate, 10% glycerol
and 0.1 M dithiothreitol) supplemented with Halt protease and
phosphatase inhibitor cocktail (ThermoFisher Scientific).
Supplementary Material
Supplementary Material is available at HMG online.
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